DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lubiprostone

Lubiprostone

  • Gastrointestinal (GI) Motility, Chronic Therapeutic Class Review

    Gastrointestinal (GI) Motility, Chronic Therapeutic Class Review

  • Inflammatory Bowel Disease Irritable Bowel Syndrome

    Inflammatory Bowel Disease Irritable Bowel Syndrome

  • Therapeutic Class Overview Irritable Bowel Syndrome Agents

    Therapeutic Class Overview Irritable Bowel Syndrome Agents

  • United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar

    United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar

  • Amitiza (Lubiprostone) Capsule, 24 Mcg and 8 Mcg

    Amitiza (Lubiprostone) Capsule, 24 Mcg and 8 Mcg

  • Identification of Pparγ Ligands with One-Dimensional Drug Profile Matching

    Identification of Pparγ Ligands with One-Dimensional Drug Profile Matching

  • Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-Mediated Pathway

    Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-Mediated Pathway

  • Cytarabine Analogues by Ion-Pairing LC-MS/MS

    Cytarabine Analogues by Ion-Pairing LC-MS/MS

  • Pharmaceuticals As Environmental Contaminants

    Pharmaceuticals As Environmental Contaminants

  • Interactions with HBV Treatment

    Interactions with HBV Treatment

  • 2015.09 IBS Drug Class Review.Pdf

    2015.09 IBS Drug Class Review.Pdf

  • OUH Formulary Approved for Use in Breast Surgery

    OUH Formulary Approved for Use in Breast Surgery

  • Preferred Drug List (PDL) Lista De Medicamentos Preferidos (PDL)

    Preferred Drug List (PDL) Lista De Medicamentos Preferidos (PDL)

  • Biotrial Bioanalytical Services Inc. Global List of Validated Bioanalytical Assays

    Biotrial Bioanalytical Services Inc. Global List of Validated Bioanalytical Assays

  • Drugs of Choice 2019

    Drugs of Choice 2019

  • Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders

    Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders

  • FDA Denial of Petition on Amitiza

    FDA Denial of Petition on Amitiza

  • PDL)/Non-Preferred Drug List (NPDL

    PDL)/Non-Preferred Drug List (NPDL

Top View
  • Use of Lubiprostone in Constipating Disorders and Its Potential for Opioid-Induced Bowel Dysfunction
  • Brand Generic Guide
  • Medicaid List of Covered Drugs (Formulary)
  • Lubiprostone
  • DRUG REFERENCE GUIDE Pharmacy Solutions | Durable Medical Equipment | Case Management | Utilization Services Frequently Prescribed Medications by Brand Name
  • Prescription Drug List Changes
  • CRITERIA for DRUG COVERAGE Lubiprostone (Amitiza)
  • NYP ACN-PAP Formulary: Fall 2009 A. 8-MOP (Methoxsalen) Amitiza
  • Treatment of an Acetaminophen Overdose Mate M
  • Amitiza and Linzess
  • Potentially Harmful Drugs in the Elderly: Beers List and More
  • NYS Medicaid Fee-For-Service Preferred Drug List PREFERRED DRUG LIST – TABLE of CONTENTS I
  • Management of Chronic Constipation in Adults
  • July 1, 2021 Premium Formulary Exclusions & Preferred Specialty Prior Authorization Requirements
  • Lubiprostone Prevents NSAID-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators Via EP4 Receptors
  • Amitiza (Lubiprostone) Capsules • Patients Taking Amitiza May Experience Dyspnea Within an Initial U.S
  • Study Report Number: SAG/0211PFC-1131-01 Version Number: 1.0
  • A Treatment Guide to Parkinson's Disease


© 2024 Docslib.org    Feedback